IDiyas

For the Inventor, By the Inventor

Kyungki-do, South Korea

Sun-Gan Chung

USPTO Granted Patents = 10


Average Co-Inventor Count = 7.1

ph-index = 4

Forward Citations = 57(Granted Patents)


Location History:

  • Kunpo, KR (1999)
  • Seoul, KR (1998 - 2000)
  • Kyungki-do, KR (2000 - 2007)
  • Suwon-si, KR (2010)

Company Filing History:

goldMedal8 out of 13 
 
Samjin Pharmaceutical Co., Ltd.
 patents
silverMedal1 out of 1 
 
Samjin Pharmaceuticazl Co., Ltd.
 patent
bronzeMedal1 out of 1 
 
Korea Research Inst. of Chem. Tech.
 patent
4. 1 out of 2 
 
Samjin Pharm. Co., Ltd.
 patents
where one patent can have more than one assignee

Years Active: 1998-2010

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 7851479 - Use of pyrimidinedione derivative for preventing or treating hepatitis C (2010-12-14),
2. 7230105 - 9-aminoacridine derivatives and process for the preparation thereof (2007-06-12),
3. 6987114 - Antiviral pyrimidinedione derivatives and process for the preparation thereof (2006-01-17),
4. 6683184 - Piperazine derivatives and process for the preparation thereof (2004-01-27),
5. 6620936 - 9-aminoacridine derivatives and process for the preparation thereof (2003-09-16),
6. 6274732 - Process for the preparation of 1-[(cyclopent-3-en-1-yl)-methyl]-5-ethyl-6-(3,5-dimethylbenzoyl)-2,4-pyrimidinedione (2001-08-14),
7. 6136815 - Antiviral 2,4-pyrimidinedione derivatives and process for the (2000-10-24),
8. 6028195 - Piperazine derivatives and process for the preparation thereof (2000-02-22),
9. 5922727 - Antiviral substituted pyrimidinedione homocarbocyclic nucleoside (1999-07-13),
10. 5780472 - Piperazine derivatives and methods for the preparation thereof and (1998-07-14),

Title: Innovator Sun-Gan Chung: Pioneering Patents in Pharmaceutical Research

Introduction

Sun-Gan Chung, an accomplished inventor based in Kyungki-do, South Korea, has made significant contributions to the field of pharmaceutical research. With a remarkable portfolio of 10 patents, he has focused on developing innovative solutions to combat various health challenges, particularly in the realms of viral infections and cancer therapies.

Latest Patents

Among his latest patents, Chung has developed a novel use of pyrimidinedione derivative for preventing or treating hepatitis C. This pyrimidinedione derivative, represented by a specific formula, demonstrates exceptional inhibitory activity against the hepatitis C virus. Another noteworthy invention is his work on 9-aminoacridine derivatives, which includes a new compound exhibiting notable antitumor activity and reduced toxicity. These inventions highlight his commitment to advancing healthcare through scientific innovation.

Career Highlights

Chung has been associated with respected companies that focus on pharmaceutical development, including Samjin Pharmaceutical Co., Ltd. and Samjin Pharmaceutical Co., Ltd. His work within these organizations has facilitated the translation of his inventive ideas into practical applications that can significantly impact public health.

Collaborations

Throughout his career, Sun-Gan Chung has collaborated with eminent colleagues, including Eui-Hwan Cho and Ho-Seok Kwon. These partnerships have been instrumental in fostering an environment of shared knowledge and innovation, enabling the successful advancement of several significant projects.

Conclusion

Sun-Gan Chung stands out as a prolific inventor within the pharmaceutical industry. His dedication to addressing critical health issues through innovation is evident in his patent portfolio and collaborative efforts. As he continues to explore new avenues in research, his impact on the field is poised to grow, potentially benefiting countless individuals fighting against diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…